Therapies for treating glioblastoma brain cancer can be delivered with greater precision and existing drugs can be used in new ways. These are the conclusions from a stud investigating a large number of cell samples from patients with brain tumors. The researchers have characterized how changes in glioblastoma cells influence the effect of different drugs.
